When assessing 11C-DED binding in all individual cortical ROIs, significant negative correlations with plasma GFAP concentration were detected in widespread, mainly frontotemporal cortical ROIs, in both ADAD mutation carriers and patients with sporadic Alzheimer’s disease separately (Fig. 3C). The gene discussed is GFAP; the disease is early-onset autosomal dominant Alzheimer disease.